Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most frequent causes of cancer-related death. Sorafenib, a multitarget angiogenesis inhibitor, is an approved frontline treatment for advanced HCC in Western countries, although a complete response (CR) to treatment is infrequently reported. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandi, Giovanni, Venturi, Michela, De Lorenzo, Stefania, Garuti, Francesca, Frega, Giorgio, Palloni, Andrea, Garajovà, Ingrid, Abbati, Francesca, Saccoccio, Gioconda, Golfieri, Rita, Pantaleo, Maria Abbondanza, Barbera, Maria Aurelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020209/
https://www.ncbi.nlm.nih.gov/pubmed/29941039
http://dx.doi.org/10.1186/s40880-018-0312-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020209/
https://www.ncbi.nlm.nih.gov/pubmed/29941039
http://dx.doi.org/10.1186/s40880-018-0312-1

Ejemplares similares